In lung adenocarcinoma (LUAD), NPSR1-AS1 is part of an eight-lncRNA signature associated with prognosis and immune infiltration, reflecting its potential as both a prognostic biomarker and a modulator of tumor immunity [69,101]. The gene discussed is NPSR1; the disease is neoplasm.